Comment on "Diabetic MAFLD is associated with increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis patients"

被引：0
|
作者：
Zhao, Gang [1 ]
Shi, Xiaobao [2 ]
Zhang, Lingyun [3 ]
Liang, Hongyuan [1 ]
机构：
[1] China Med Univ, Shengjing Hosp, Dept Radiol, Shenyang, Peoples R China
[2] China Med Univ, Affiliated Hosp 4, Dept Radiol, Shenyang, Peoples R China
[3] China Med Univ, Hosp 1, Dept Med Oncol, Shenyang, Liaoning, Peoples R China
来源：
INTERNATIONAL JOURNAL OF CANCER | 2024年 / 154卷 / 07期
关键词：
D O I：
10.1002/ijc.34796
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1324 / 1325
页数：2
相关论文
共 50 条
  • [1] Diabetic MAFLD is associated with increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis patients
    Kim, Mi Na
    Han, Kyungdo
    Yoo, Juhwan
    Hwang, Seong Gyu
    Zhang, Xuehong
    Ahn, Sang Hoon
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2023, 153 (08) : 1448 - 1458
  • [2] Reply to: Comments on "Diabetic MAFLD is associated with increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis patients"
    Kim, Mi Na
    Zhang, Xuehong
    Ahn, Sang Hoon
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2024, 154 (07) : 1326 - 1327
  • [3] DIABETIC METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE IS ASSOCIATED WITH INCREASED RISK OF HEPATOCELLULAR CARCINOMA AND MORTALITY IN CHRONIC VIRAL HEPATITIS PATIENTS
    Kim, Mi Na
    Han, Kyungdo
    Yoo, Juhwan
    Hwang, Seong-Gyu
    Ahn, Sang Hoon
    [J]. HEPATOLOGY, 2022, 76 : S244 - S245
  • [4] Increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis with concurrent fatty liver
    Kim, Mi Na
    Han, Kyungdo
    Yoo, Juhwan
    Hwang, Seong Gyu
    Ahn, Sang Hoon
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (01) : 97 - 107
  • [5] CONCURRENT FATTY LIVER IS ASSOCIATED WITH HIGHER RISK OF HEPATOCELLULAR CARCINOMA AND MORTALITY IN PATIENTS WITH CHRONIC VIRAL HEPATITIS
    Kim, Mi Na
    Han, Kyungdo
    Yoo, Juhwan
    Hwang, Seong-Gyu
    Ahn, Sang Hoon
    [J]. HEPATOLOGY, 2021, 74 : 450A - 450A
  • [6] RISK OF HEPATOCELLULAR CARCINOMA IN CHRONIC VIRAL HEPATITIS
    Kane, Lara J.
    Macdonald, Graeme A.
    [J]. CANCER FORUM, 2009, 33 (02)
  • [7] Metabolic dysfunction-associated fatty liver disease subgroups and risk of hepatocellular carcinoma and mortality in patients with chronic viral hepatitis
    Kim, Mi Na
    Han, Kyungdo
    Yoo, Juhwan
    Hwang, Seong Gyu
    Ahn, Sang Hoon
    [J]. JOURNAL OF HEPATOLOGY, 2022, 77 : S100 - S100
  • [8] Hepatitis B viremia is associated with increased risk of hepatocellular carcinoma in chronic carriers
    Tang, BQ
    Kruger, WD
    Chen, G
    Shen, FM
    Lin, WY
    Mboup, S
    London, WT
    Evans, AA
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2004, 72 (01) : 35 - 40
  • [9] Screening is associated with a lower risk of hepatocellular carcinoma-related mortality in patients with chronic hepatitis B
    Su, Feng
    Weiss, Noel S.
    Beste, Lauren A.
    Moon, Andrew M.
    Jin, Ga-Young
    Green, Pamela
    Berry, Kristin
    Ioannou, George N.
    [J]. JOURNAL OF HEPATOLOGY, 2021, 74 (04) : 850 - 859
  • [10] Lipophilic Statins and Risk of Hepatocellular Carcinoma and Mortality: A Prospective, Nationwide Population with Chronic Viral Hepatitis
    Simon, Tracey G.
    Duberg, Ann-Sofi
    Aleman, Soo
    Hagstrom, Hannes
    Chung, Raymond T.
    Ludvigsson, Jonas F.
    [J]. HEPATOLOGY, 2018, 68 : 59A - 60A
12345